Showing results (221-230 of 406) with videos related to
Sort By:
Pageof 41
Cancer Research|February 18, 2017
Prominent Oncogenic Roles of EVI1 in Breast CarcinomaHui Wang, Thorsten Schaefer, Martina Konantz, et al.MDM Policy & Practice|February 8, 2019
Development of an Initial Conceptual Model of Multiple Myeloma to Support Clinical and Health Economics Decision MakingSebastian Gonzalez-McQuire, Meletios-Athanassios Dimopoulos, Katja Weisel, et al.Anti-Cancer Drugs|May 29, 2004
Prospective multicenter phase II study of irinotecan as third-line therapy in metastatic colorectal cancer and progression after bolus and infusional 5-fluorouracilJoerg Thomas Hartmann, Karin Oechsle, Elke Jäger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2007
Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationAnna Sureda, Stephen Robinson, Carmen Canals, et al.Stem Cells Translational Medicine|January 4, 2013
Shared cell surface marker expression in mesenchymal stem cells and adult sarcomasStefan Wirths, Elke Malenke, Torsten Kluba, et al.Annals of the New York Academy of Sciences|August 21, 2012
Phenotypic and functional heterogeneity of human bone marrow- and amnion-derived MSC subsetsKavitha Sivasubramaniyan, Daniela Lehnen, Roshanak Ghazanfari, et al.European Journal of Haematology|January 8, 2025
Pomalidomide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Survival and Subgroup Analyses From the OPTIMISMM TrialPaul Richardson, Meral Beksaç, Albert Oriol, et al.Leukemia & Lymphoma|September 23, 2017
Carfilzomib-dexamethasone versus subcutaneous or intravenous bortezomib in relapsed or refractory multiple myeloma: secondary analysis of the phase 3 ENDEAVOR studyHartmut Goldschmidt, Philippe Moreau, Heinz Ludwig, et al.International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|June 1, 2013
SOX2 expression and prognostic significance in ovarian carcinomaDeborah L Pham, Veit Scheble, Petra Bareiss, et al.Haematologica|April 12, 2012
Haploidentical allogeneic hematopoietic cell transplantation in adults using CD3/CD19 depletion and reduced intensity conditioning: a phase II studyBirgit Federmann, Martin Bornhauser, Christoph Meisner, et al.Pageof 41